Nathan Treybeck
Stock Analyst at Wells Fargo
(1.35)
# 3,477
Out of 5,182 analysts
29
Total ratings
29.41%
Success rate
-3.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Holdings | Maintains: Overweight | $200 → $180 | $120.80 | +49.01% | 8 | May 1, 2026 | |
| RMD ResMed | Maintains: Equal-Weight | $270 → $227 | $205.02 | +10.72% | 3 | May 1, 2026 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $51 → $34 | $24.63 | +38.04% | 10 | Feb 26, 2026 | |
| LMAT LeMaitre Vascular | Maintains: Equal-Weight | $87 → $94 | $112.04 | -16.10% | 3 | Feb 26, 2026 | |
| ITGR Integer Holdings | Maintains: Equal-Weight | $72 → $84 | $84.03 | -0.04% | 5 | Feb 20, 2026 |
iRhythm Holdings
May 1, 2026
Maintains: Overweight
Price Target: $200 → $180
Current: $120.80
Upside: +49.01%
ResMed
May 1, 2026
Maintains: Equal-Weight
Price Target: $270 → $227
Current: $205.02
Upside: +10.72%
PROCEPT BioRobotics
Feb 26, 2026
Maintains: Overweight
Price Target: $51 → $34
Current: $24.63
Upside: +38.04%
LeMaitre Vascular
Feb 26, 2026
Maintains: Equal-Weight
Price Target: $87 → $94
Current: $112.04
Upside: -16.10%
Integer Holdings
Feb 20, 2026
Maintains: Equal-Weight
Price Target: $72 → $84
Current: $84.03
Upside: -0.04%